The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Trubnikova L.I.

Ulyanovsk State University

Marinova O.A.

Ulyanovsk State University

Correlation dependence of tissue inhibitor of metalloproteinase-1 levels and follicular fluid morphology in patients with combined (uterine myoma and endometriosis) infertility in the ART-programs

Authors:

Trubnikova L.I., Marinova O.A.

More about the authors

Read: 1114 times


To cite this article:

Trubnikova LI, Marinova OA. Correlation dependence of tissue inhibitor of metalloproteinase-1 levels and follicular fluid morphology in patients with combined (uterine myoma and endometriosis) infertility in the ART-programs. Russian Bulletin of Obstetrician-Gynecologist. 2024;24(4):21‑28. (In Russ.)
https://doi.org/10.17116/rosakush20242404121

Recommended articles:
The expe­rience of using the nasal form of GnRH agonists in in vitro fertilization programs. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):79-84
Stru­ctural and biochemical features of menstrual discharge in patients with uterine fibroids. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):85-90
Reproductive aspe­cts in the treatment of colo­rectal endo­metriosis. Russian Journal of Human Reproduction. 2024;(6):140-148

References:

  1. Clinical recommendations «Female infertility (modern approaches to diagnosis and treatment)» (together with «Clinical recommendations (treatment protocol)»: Approved by the Ministry of Health of the Russian Federation. Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. Approval date 2021. Developer: LLC «Russian Society of Obstetricians and Gynecologists» (ROAG), Russian Association of Human Reproduction (RAHR). (In Russ.).
  2. Ermakova OA. Female and male infertility as a problem of the 21st century. Molodoi uchenyi. 2019;243:5:46-49. (In Russ.). https://moluch.ru/archive/243/56098/
  3. Polyakova TV. Studying the effectiveness of in vitro fertilization and its complications in Russia. Mezhdunarodnyi studencheskii nauchnyi vestnik. 2021;6:16. (In Russ.). https://eduherald.ru/ru/article/view?id=20750
  4. Orazov MR, Mikhaleva LM, Lefard ML. Infertility in women of reproductive age caused by uterine fibroids: pathogenesis and ways of overcoming. Trudnyi patsient. 2021;19:7:16-19. (In Russ.).
  5. Tolibova GH, Tral’ TG, Kakhiani MI, Kogan IYu. Endometrial hyperplasia in women with external genital endometriosis and uterine fibroids. Russian Bulletin of Obstetrician-Gynecologist. 2020;20:6:90-95. (In Russ.). https://doi.org/10.17116/rosakush20202006190
  6. Clinical guidelines «Endometrial hyperplasia». Approved by the Ministry of Health of the Russian Federation. Approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. Approval date 2021. Developer: Russian Society of Obstetricians and Gynecologists LLC (ROAG). (In Russ.).
  7. Chistyakova GN, Grishkina AA, Remizova II. Endometrial hyperplasia: classification, features of pathogenesis, diagnostics (literature review). Russian Journal of Human Reproduction. 2018;24:5:53-57. (In Russ.). https://doi.org/10.17116/repro20182405153
  8. Krasnopol’skaya KV, Novikova OV, Isakova KM, Shostenko LV, Rau DI, Shishkina AV. Expediency of preimplantation genetic testing for aneuploidy in vitro fertilization programs in patients after conservative treatment of atypical hyperplasia and initial endometrial cancer. Akusherstvo i ginekologiya. 2023;1:76-82. (In Russ.). https://doi.org/10.18565/aig.2022.245
  9. Grigorkevich OS, Makarov GV, Kosova LYu. Matrix metalloproteinases and their inhibitors. Farmakokinetika i farmakodinamika. 2019;2:3-16. (In Russ.).
  10. Kushlinskii NE, Gershtein ES. Investigation of matrix metalloproteinases and their tissue inhibitors in tumors and peripheral blood of cancer patients. Laboratornaya sluzhba. 2013;1:25-38. (In Russ.).
  11. Gerstein ES, Kushlinsky DN, Adamyan LV, Tereshkina IV, Laktionov KP. Matrix metalloproteinases and their tissue inhibitors in the clinical course of ovarian cancer (literature review). Molekulyarnaya meditsina. 2013;6:11-20. (In Russ.).
  12. Rogova LN, Shesternina NV, Zamechnik TV, Fastova IA. Matrix metalloproteinases, their role in physiological and pathological processes (literature review). Vestnik novykh meditsinskikh tekhnologii. 2011; XVIII:2:86-89. (In Russ.).
  13. Yarmolinskaya MI, Molotkov AS, Denisovf VM. Matrix metalloproteinases and inhibitors: classification, mechanism of action (literature review). Zhurnal akusherstva i zhenskikh boleznei. 2012;LXI:1:113-125. (In Russ.).
  14. Dolzhnikov AA, Churnosov MI, Pakhomov SP, Orlova VS, Bykov PM, Mukhina TS, Nagornyi AV, Alpukhova OB. Molecular genetic factors of prognosis of smooth muscle neoplasms of the uterus: the role of matrix metalloproteinases (literature review). Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e». 2012;2:138-146. (In Russ.).
  15. Sidorova IS, Ageev MB. Clinical and morphological features of simple and proliferating uterine fibroids. Russian Bulletin of Obstetrician-Gynecologist. 2013;13:6:34-38. (In Russ.).
  16. Teplyakov AT, Andriyanova AV, Pushnikova EYu, Suslova TE, Nikonova ES, Konakov SN, Rodionova OA, Kuznetsova AV, Protopopova NV. Tissue inhibitor of matrix metalloproteinases (TIMP-1) as an independent marker of ischemic myocardial remodeling in chronic heart failure. Sibirskii zhurnal klinicheskoi i eksperimental’noi meditsiny. 2014;29:2:28-34. (In Russ.).
  17. He T, Wang J, Wang XL, Deng WS, Sun P. Association between the matrix metalloproteinase-9 rs3918242 polymorphism and ischemic stroke susceptibility: A Meta-Analysis. J Stroke Cerebrovasc Dis. 2017;26:5:1136-1143. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.12.036
  18. Lewinski A, Brona A, Lewandowski KC, Jedrzejuk D, Bohdanowicz-Pawlak A, Skowronska-Jozwiak E, Bienkiewicz M, Milewicz A. Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin-1. Thyroid Res. 2013;6:1:9. 
  19. Bieniaś B, Sikora P. Selected metal matrix metalloproteinases and tissue inhibitors of metalloproteinases as potential biomarkers for tubulointerstitial fibrosis in children with unilateral hydronephrosis. Dis Markers. 2020;2020:9520309. https://doi.org/10.1155/2020/9520309
  20. Shabalin VN, Shatokhina SN. Functional morphology of non-cellular human tissues. M.: RAN; 2019;360. (In Russ.).
  21. Shatokhina SN. Functional morphology of biological fluids is a new direction in clinical laboratory diagnostics. Al’manakh klinicheskoi meditsiny. 2008;18:50-56. (In Russ.).
  22. Shatokhina SN, Shabalin VN. Atlas of structures of non-cellular human tissues in norm and pathology: [in 3 volumes]. Vol. 1: Morphological structures of urine. Tver’: LLC «Publishing house «Triada»; 2011;240. (In Russ.).
  23. Shatokhina SN, Shabalin VN. Atlas of structures of non-cellular human tissues in norm and pathology: [in 3 volumes]. Vol. 2: Morphological structures of blood serum. Tver’: LLC «Publishing house «Triada»; 2013;240. (In Russ.).
  24. Zakharova GL, Shabalin VV, Yanov YuK, Tyrkova EV, Klyachko LL, Shabalina ON. Patent No. 2293324 Russian Federation, IPC C2, G01 33/487 Method of obtaining biological fluid for morphological examination: No. 2005110264/15: application 03.30.2005: publ. 10.02.2007; applicants and patent holders State Institution St. Petersburg-St. Petersburg Scientific Research Institute of Ear, Throat, Nose and Speech. — 3 p. (In Russ.).
  25. Marinova OA, Trubnikova LI, Albutova ML. Prognostic value of determination of matrix metalloproteinase-1 and its tissue inhibitor in follicular fluid in patients in in vitro fertilization programs. Gynekologiya. 2021;23:6:542-547. (In Russ.). https://gynecology.orscience.ru/2079-5831/article/view/71326

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.